MISSIONPHARMA A/S — Credit Rating and Financial Key Figures

CVR number: 26902398

Vassingerødvej 9, 3540 Lynge

info@missionpharma.com

tel: 48163248

Income statement (mDKK)

	2022	2023	2024
Fiscal period length	12	12	12
Net sales	942.49	940.12	741.96
Costs of manufacturing	- 592.48	- 560.02	- 482.87
External services	- 135.08	- 176.51	- 111.08
Gross profit	214.93	203.59	148.01
Employee benefit expenses	-56.41	-56.97	-56.91
Other operating expenses	-0.75	-1.38	-1.78
Total depreciation	-1.55	-1.42	-1.36
EBIT	156.22	143.82	87.95
Other financial income	1.98	5.59	18.31
Other financial expenses	-6.12	-2.77	-17.21
Net income from associates (fin.)	1.72	5.52	4.07
Pre-tax profit	153.79	152.17	93.12
Income taxes	-33.78	-32.30	-19.71
Net earnings	120.01	119.86	73.40

	2022	2023	2024
Development expenditure		1.29	12.56
Intangible assets total		1.29	12.56
Land and waters	21.30	20.34	19.41
Buildings	1.58	1.84	1.45
Tangible assets total	22.88	22.18	20.86
Holdings in group member companies	36.46	34.31	37.30
Other non-current investments	36.46
Investments total	72.91	34.31	37.30
Non-current loans receivable	-36.02
Long term receivables total	-36.02
Finished products/goods	37.80	45.54	34.69
Inventories total	37.80	45.54	34.69
Current trade debtors	42.36	37.63	60.15
Current amounts owed by group member comp.	330.45	275.91	185.16
Prepayments and accrued income	58.15	9.24	24.76
Current other receivables	2.94	4.93	1.28
Current deferred tax assets	12.19	19.63	17.19
Short term receivables total	446.11	347.35	288.54
Cash and bank deposits	11.22	19.71	9.26
Cash and cash equivalents	11.22	19.71	9.26
Balance sheet total (assets)	554.90	470.38	403.20

	2022	2023	2024
Share capital	2.10	2.10	2.10
Asset revaluation reserve			12.56
Shares repurchased	150.00	119.00	73.00
Other reserves	34.24	35.10	38.17
Retained earnings	43.37	43.25	73.90
Profit of the financial year	120.01	119.86	73.40
Shareholders equity total	349.72	319.32	273.13
Provisions	7.62	9.75	12.07
Non-current other liabilities	7.62	9.75	12.07
Non-current liabilities total	7.62	9.75	12.07
Advances received	104.28	76.37	48.42
Current trade creditors	55.38	27.12	48.33
Current owed to group member	9.07	7.09	2.78
Other non-interest bearing current liabilities	28.83	30.74	18.46
Current liabilities total	197.56	141.32	118.00
Balance sheet total (liabilities)	562.52	480.13	415.28

CreditReports API